Testing wakame seaweed for kidney disease patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether eating a daily dose of wakame seaweed can lower certain waste products (AGEs) in your blood that build up with kidney disease. It's for people with moderate chronic kidney disease who are already on standard protective medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 89 years old
- You have stage 3 chronic kidney disease (moderate kidney function decline)
- You are already taking medications to protect your kidneys (like ACE inhibitors or SGLT2 inhibitors)
- You are not pregnant or breastfeeding
- You do not have uncontrolled thyroid problems or heart failure that is getting worse
- You are not taking other seaweed or iodine supplements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether providing healthy food like fruits and vegetables can help protect the kidneys of people with early kidney disease. It aims to see if a better diet can slow down kidney damage and improve overall kidney health.
This study tests whether a traditional Chinese medicine called Niaoduqing Granules can help improve kidney function in people over 60 with chronic kidney disease. It may offer a new way to manage the condition without dialysis.
This trial tests a medication called EC5026 in people with and without chronic kidney disease (CKD) to see how the body handles it. It helps understand if dose adjustments are needed for people with impaired kidney function.
This study tests whether eating mostly plants (with some animal products) can safely help people with moderate kidney disease. Researchers will compare this diet to a standard kidney-friendly diet and see how it affects kidney function and overall health.
This trial tests whether eating walnuts every day can help protect the heart and kidneys in people with chronic kidney disease. It may help improve blood pressure, cholesterol, and blood sugar control.
This trial studies an oral product (a “uremic toxin” absorber) plus probiotics to help slow the progression of chronic kidney disease. It may help by lowering harmful gut-related substances that can build up when kidney function is reduced.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.